Ruxolitinib Phosphate in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Clinical trial NCT03041636 · COMPLETED
Trial details
- NCT number
- NCT03041636
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-08
- Primary completion
- 2020-04-29
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.